|
Merck Dulera shows efficacy in COPD treatment
Pharmaceutical Business Review Dulera Inhalation Aerosol, which is used to treat asthma combines mometasone furoate, an inhaled corticosteroid, and formoterol fumarate, a long-acting beta2-agonist. The two 26-week, multicenter, double-blind, placebo controlled trials comprising 2251 … Merck Announces Presentation of Phase III Investigational Studies Evaluating … |
View full post on asthma – Google News